Users online: 2083    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2015, Volume : 8, Issue : 11
First page : ( 1598) Last page : ( 1602)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2015.00287.5

Adverse Drug Reactions in Bangladeshi Health Care Setup: An Update

Umar Badar Uddin1, Haque Mainul2,*

1Faculty of Medicine, AIMST University, Semeling, 08100 Bedong, Kedah, Malaysia

2Faculty of Medicine, Universiti Sultan Zainal Abidin, Medical Campus, Jalan Sultan Mahmud, 20400 Kuala Terengganu, Terengganu, Malaysia

*Corresponding Author E-mail: runurono@gmail.com

Online published on 1 January, 2016.


The safety of medicines has been a major issue involving health care delivery systems worldwide. Adverse drug reactions (ADRs) cause a huge burden accounting for considerable morbidity, mortality, andextra costs both developed and developing nations. Monitoring ADRs and pharmacovigilance (PV) is not adequate in many developing countries like Bangladesh. A literature search revealed only a few publications on ADRs in Bangladesh. These scientific reports revealed that the rate of ADRs are comparable with many countries, but the alarming issue is regulatory agencies are not much concern about the atrocities of ADRs. Despite the existing functional government organizations for monitoring ADRs which reports ADR cases to the WHO, it fails to keep pace with the current global situation. The Government of Bangladesh and other stakeholders should take up immediate initiatives in boosting up monitoring, and enhance awareness to report ADRs by the doctors, nurses, pharmacist and patients. PV studies and research on ADRs in Bangladesh should be encouraged.



Adverse drug reactions, pharmacovigilance, Steven Johnson's Syndrome, antibiotics, Fluoroquinolones.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
514,397,840 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.